Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis

Area of Science:

• Neuroscience
• Aging Research
• Endocannabinoid System

Background:

• Endocannabinoid (eCB) signaling, mediated by cannabinoid receptor type 1 (CB1), is crucial for cognitive function.
• Reduced eCB signaling in the hippocampus of aged mice correlates with cognitive decline and brain changes.
• The precise role of eCB system modulation in cognitive aging requires further investigation.

Purpose of the Study:

• To investigate the age-dependent alterations in the endocannabinoid system across different brain regions in mice.
• To identify specific eCB components and their changes during the aging process.
• To determine if middle age represents a critical window for eCB system changes impacting cognitive aging.

Main Methods:

• Utilized five distinct age groups of mice, from adolescence to old age.
• Employed complementary techniques including Western blotting and quantitative autoradiography.
• Analyzed key eCB components such as anandamide (AEA), 2-arachidonoylglycerol (2-AG), and CB1 receptor expression and binding.

Main Results:

• The endocannabinoid system shows significant alterations in middle-aged mice (9-12 months).
• 2-arachidonoylglycerol (2-AG) levels decreased prominently in the hippocampus, while anandamide (AEA) decreased in the caudate putamen and prefrontal cortex.
• CB1 receptor binding increased in the hippocampus and lateral entorhinal cortex during middle and old age, despite initial protein level changes.

Conclusions:

• A 'middle-age crisis' in the endocannabinoid system is identified, characterized by region-specific changes.
• These findings suggest middle age is a critical period for eCB system dysfunction.
• Targeting the eCB system during this middle-age window may offer a novel therapeutic strategy for mitigating cognitive aging.